Your browser doesn't support javascript.
loading
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials.
Li, Lee X; Cappuzzo, Federico; Matos, Ignacio; Socinski, Mark A; Hopkins, Ashley M; Sorich, Michael J.
Afiliação
  • Li LX; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Cappuzzo F; Oncology Department, Istituto Nazionale Tumori IRCCS "Regina Elena", Rome, Italy.
  • Matos I; Department of Oncology, Clinica Universidad de Navarra, Madrid, Spain.
  • Socinski MA; Research Department of Haematology, Cancer Immunology Unit, University College London Cancer Institute, London, UK.
  • Hopkins AM; Thoracic Oncology, AdventHealth Cancer Institute, Orlando, FL, USA.
  • Sorich MJ; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
Oncologist ; 28(4): e205-e211, 2023 04 06.
Article em En | MEDLINE | ID: mdl-36905578
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article